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Abstract
Alzheimer’s disease (AD) is the most frequent cause of dementia. The clinical symptoms of AD begin with impairment of
memory and executive function followed by the gradual involvement of other functions, such as language, semantic
knowledge, abstract thinking, attention, and visuospatial abilities. Visuospatial function involves the identification of a
stimulus and its location and can be impaired at the beginning of AD. The Visual Object and Space Perception (VOSP)
battery evaluates visuospatial function, while minimizing the interference of other cognitive functions.
Objectives: To evaluate visuospatial function in early AD patients using the VOSP and determine cutoff scores to
differentiate between cognitively healthy individuals and AD patients.
Methods: Thirty-one patients with mild AD and forty-four healthy elderly were evaluated using a neuropsychological
battery and the VOSP.
Results: In the VOSP, the AD patients performed more poorly in all subtests examining object perception and in two
subtests examining space perception (Number Location and Cube Analysis). The VOSP showed good accuracy and good
correlation with tests measuring visuospatial function.
Conclusion: Visuospatial function is impaired in the early stages of AD. The VOSP battery is a sensitive battery test for
visuospatial deficits with minimal interference by other cognitive functions.
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Introduction
Dementia is a syndrome characterized by the impairment of
cognitive functions, such as memory, language, abstraction,
organization, planning, attention, and visuospatial skills [1]. These
deficits, which are associated with a decline in the performance of
everyday activities, are crucial for the diagnosis of dementia [2]. In
general, the course of AD begins with the impairment of memory
and executive functions followed by the gradual involvement of
other functions, including complex visual disturbance [3,4].
Visuospatial function in AD can be impaired at the beginning of
the disease, declining gradually with the progression of the disease,
and can lead to visual agnosia [5]. The visuospatial deficits appear
primarily as difficulties with reading, problems in discriminating
form and color, an inability to perceive contrast, difficulties in
visual spatial orientation and motion detection, agnosia and
difficulty in developing visual strategies [6]. These deficits are
related to the presence os neuropathology in the visual association
cortex [4]. Katz and Rimmer [7] observed numerous plaques and
neurofibrillary tangles in the visual association areas in patients
without primary visual deficits, which may underlie these deficits.
The assessment of these deficits is important in providing more
diagnostic information for dementia and new perspectives for
intervention.
Visuospatial function involves identification of a stimulus and its
location. The tasks of identifying and locating objects activate
different cortical areas, such as Brodmann area 5 of the superior
parietal lobe, the parieto-occipital junction and the premotor areas
[7,8,9]. As well as these tasks activate distinct neural circuits that
project from the striate cortex and to the occipitotemporal (ventral
pathway) and occipitoparietal (dorsal pathway) cortices, respec-
tively [10,11]. The ventral pathway acts in the visual recognition
of objects, whereas the dorsal pathway acts in the recognition of
space [12].
Most neuropsychological tests that evaluate visuospatial func-
tion require other cognitive skills [13]. For example, the Cubes test
(WAIS-III), Rey Complex Figure test, and the clock drawing test
require visuoconstructive skills [2], and Hooper’s Test requires
analysis and visual synthesis. However, some tests assess only visual
orientation and consist of finding objects in space. Some tests
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involve tasks that assess visual perception and the spatial
discrimination of position [8], such as the cancellation tests and
the Judgment of Line Orientation test. Among these latter
methods is the Visual Object and Space Perception (VOSP)
battery [14,15].
The VOSP battery evaluates space and object perception, and
the battery proceeds from the assumption that these perceptions
are functionally independent [8]. The subtests require simple
responses, and each of them focuses on one component of visual
perception, while minimizing the involvement of other cognitive
skills [15].
The VOSP battery seems to be sensitive to changes in
visuospatial function in various diseases, e.g., posterior cortical
atrophy [16] and Lewy body dementia [17]. Additionally, the
VOSP has been reported to detect a lack of impairment in
visuospatial functions in Huntington’s disease patients [12] and
patients with atypical parkinsonian syndromes [18].
Some studies were developed with elderly people and patients
with dementia to assess visuospatial function with the VOSP. A
survey of healthy elderly using the VOSP battery was conducted in
Spain and showed that age was a strong predictor of scores on all
subtests, that educational level affected some subtests (Object
Decision and Silhouettes), and that gender had no significant effect
[19].
In patients with dementia, a portion of the VOSP subtests were
used in a study that assessed visuospatial ability in driving. The
Incomplete Letters and Cube Analysis tests were used; in both
tests, the dementia patients performed significantly worse than
controls [20].
In one study comparing the performance of patients with AD,
patients with dementia with Lewy bodies and control subjects on
the subtests of the VOSP (Screening Test, Incomplete Letters,
Silhouettes, Object Decision and Cube Analysis), the patients with
early-stage dementia with Lewy bodies showed a significant
impairment in visuospatial functions, while only the late-stage AD
patients showed impairment [17].
In a longitudinal study in Italy, the VOSP battery was used to
evaluate patients with early-stage Alzheimer’s disease; in the first
wave, there was no significant impairment of visuospatial
functions, although impairments were observed in a second
evaluation eight months later on tests of spatial perception [21].
The VOSP has not been used to evaluate AD patients in Brazil.
Therefore, there is need for a study to assess visuospatial function
in AD and the sensitivity of this instrument in detecting
visuospatial deficits in early stages of AD. So, the aims of this
study were to evaluate visuospatial function in early AD patients
using the VOSP and to determine cutoff scores to differentiate
between cognitively healthy individuals and AD patients.
Methods
Population Sample
Control subjects agreed to participate in the study by signing an
informed consent form. In case of the patients with AD, that could
have a compromised capacity to consent, we asked a familiar to
fulfill and sign the consent form. The project was approved by the
Ethics Committee of the Federal University of Sa˜o Paulo (No. Of
the process: 1924/08) and Santa Marcelina Hospital.
We evaluated 75 participants, including 31 mild AD patients
who fulfilled the NINCDS-ADRDA criteria [22]. The exclusion
criteria were moderate or severe dementia, uncontrolled systemic
diseases, and uncorrected visual or hearing impairments. Patients
receiving a stable dose of cholinesterase inhibitors and/or
antidepressants for at least two months were included. Patients
with AD were recruited at outpatient cognitive units in Sa˜o Paulo
Hospital and Santa Marcelina Hospital.
The control group included 44 healthy elderly (21 women). For
these patients, the exclusion criteria were a Mini Mental State
Examination [23] score below the median level of schooling
(illiterate: 20; 1 to 4 years: 25; 5 to 8 years: 26; 9 to 11 years: 28;
more than 11 years: 29) [24]; a Geriatric Depression Scale (GDS)
[25] short version score higher than 6; a Functional Activities
Questionnaire (FAQ) score greater than or equal to 2 [26];
uncorrected sensory deficits; uncontrolled systemic diseases;
neurological or psychiatric disease; and the use of a medication
that acts on the central nervous system.
In both groups, the subjects had to have completed more than
one year of schooling, been more than 50 years of age, and had no
uncorrected visual deficits.
Neurocognitive Evaluation
The patients were evaluated in a session of about an hour and a
half with a battery of neuropsychological tests that assessed
cognitive functions and both specifically and in more depth,
visuospatial function with the VOSP battery. The project was
approved by the Ethics Committee of the Federal University of
Sa˜o Paulo (No. of the process: 1924/08) and Santa Marcelina
Hospital.
We evaluated cognitive functions of all participants with the
following instruments: Complex Figure Test, perceptual organi-
zation and visual memory [27]; Corsi Block-tapping Test,
visuospatial short-term memory (direct form) and working
memory (inverse form) [28]; Rey Auditory Verbal Learning Test
(RAVLT), verbal learning, memory and susceptibility to interfer-
ence [29]; Verbal Fluency – animal category, spontaneous
production of words under restricted conditions [30,8]; Reduced
version of Boston Naming Test – CERAD Neuropsychological
Battery, visual naming ability [31]; Cancellation task [32,33];
Raven’s Progressive Matrices – colored version, a measure of
intellectual efficiency and visuoperception [34]; Clock Drawing
Test, visuospatial and constructional abilities [35].
VOSP
Visuospatial abilities were evaluated using the eight-test VOSP
battery; four of these tests assess object perception, and four assess
space perception. At the beginning, a preliminary test of visual
sensory efficiency (Shape Detection) is performed to determine
whether the patient has sufficient visual and sensorial capacity to
complete the other subtests. All tests are untimed.
In the preliminary Shape Detection test, the patient has to
identify whether or not there is a degraded ‘‘X’’ on 20 patterned
sheets of paper. One point is given for each correct answer.
Subjects with a score of 15 or lower are not able to perform the
VOSP battery.
Subtests–object perception
N Incomplete Letters: Twenty incomplete letters are shown to
the patient, and he is asked to name or identify them. A point
is awarded for each correct answer (maximum 20).
N Silhouettes: In this activity, silhouettes (shadows) of animals
and objects are shown to the patient, and he is asked to identify
them. There are 15 silhouettes of animals and 15 silhouettes of
inanimate objects. The boards are arranged in ascending order
of difficulty, and the test should be abandoned after five errors.
In this study, to determine the cutoff scores, we applied all of
the boards, even if the examinee made more than five errors
(maximum 30).
Visuospatial Function in Early Alzheimer’s Disease
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Object Decision: Twenty boards with four stimuli are presented.
Only one of these stimuli represents something real; the other
forms are not defined (distractor stimuli). The patient is asked to
identify and name the stimulus that represents the real shape. One
point is given for each correct answer (maximum 20).
N Progressive Silhouettes: This test consists of two series in which
boards depicting an object are presented; 10 boards depict a
gun, and 10 boards show a trumpet. The first board shows the
silhouette of the object, and each successive board shows a
more complete picture of the object. The patient is asked to
identify these two objects with the smallest possible number of
boards. The number of stimuli needed to identify these objects
is recorded (maximum 20).
Subtests–space perception
N Dot Count: The patient is asked to count how many black dots
there are on a white card. There are 10 cards. A point is
awarded for every correct count (maximum 10).
N Position Discrimination: Ten boards are presented. Each
board has two squares with a black dot in the center each. In
one of the squares, the point is exactly in the center, while the
other point is slightly off-center. The patient is asked to identify
in which square the black spot is located exactly in the center.
The number of correct answers is recorded (maximum 10).
N Number Location: Ten boards are presented in this test. Each
board has two squares arranged one above the other. The top
square contains numbers arranged randomly. The bottom
square contains only a black dot. The patient is asked to
identify which number corresponds to the black dot. Each
correct identification earns one point (maximum 10).
N Cube Analysis: Ten boards are presented. Each board features
the design of solid structures. The patient is asked to identify
how many solids (cubes) there are on each board. The boards
are presented in increasing degree of difficulty (maximum 10).
Statistical Analysis
Data were analyzed using the Statistical Package for the Social
Sciences (SPSS) version 17.0. Demographic variables were
analyzed from a descriptive point of view. The chi-square test
was used to identify possible differences in the sex distribution
between the two groups. We used a nonparametric test (Mann-
Whitney) to compare the results of neuropsychological tests and to
compare the non-continuous variables. The multivariate ANOVA
was used to analyze the influence of one variable on the others. We
applied the Spearman correlation to investigate the relationship
between the subtests of the VOSP and the other neuropsycholog-
ical tests applied. We used ROC curve analysis to verify which
tests best discriminated (sensitivity and specificity) the patients
from the controls. The chosen significance level was 5% (p,0.05).
Results
The demographic and clinical data are shown in Table 1. No
difference was observed between the two groups regarding
education. However, differences were found in age: patients in
the control group were statistically younger than those in the AD
group. Given this difference, it was performed a multivariate
analysis (multivariate intra-group ANOVA) among the controls
and among the patients to evaluate how age influenced the values
of the variables of interest. This analysis evaluated each of the
variables of interest together and in relation to the variable of age
within each group. Only in the control group and only for two
variables (the Complex Figure Test Delayed Recall (p,0.001) and
Cancellation task (p = 0.019)) did age influence the test scores.
Therefore, age was not a major cause of differences between the
groups.
All of the participants in the study had scores equal to or less
than 6 on the GDS, thereby indicating no symptoms of depression.
There was a significant difference between the two groups on the
Mini Mental State Examination (p,0.01) and the FAQ (p,0.01).
The AD patients had a mean score of 10.65 (SD 4.83) on the
functional scale.
The performance of the AD patients and controls on the
neuropsychological tests is shown in Table 2. We observed a
significant difference between the performance of both groups on
all of the tests: the controls outperformed the AD patients with
respect to all cognitive skills.
The comparison of the VOSP scores of the AD patients and the
healthy elderly controls is shown in Table 3. All participants
completed the Shape Detection screening test properly, making
them eligible to continue with the VOSP. Thus, it was observed no
significant difference in the performances of the two groups on this
first test.
In the object-perception tests, it was found a significant
difference in the performance of the two groups on the four
subtests, indicating a greater difficulty of patients with AD to
perform these activities.
Table 1. Sample description.
Diagnosis
Controls (n =44) Mild AD Patients (n =31) Mann-Whitney Test
Mean (SD) Mean (SD) p-value
(Range) (Range)
Age 68.52 (7.06) 74.23 (6.93) ,0.01
(61–86) (63–86)
Education Level 9.59 (4.77) 8.16 (4.16) 0.196
(3–20) (3–19)
Sex Male Female Male Female
N 23 21 13 18 p = 0.378*
*x2 test.
doi:10.1371/journal.pone.0068398.t001
Visuospatial Function in Early Alzheimer’s Disease
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The scores on the space perception tests revealed a significant
difference between the groups on the Number Location and Cube
Analysis subtests. Conversely, the results of the Dot Counting and
Position Discrimination subtests were not significantly different
(p = 0.252, p= 0.120, respectively).
We used ROC curve analysis to differentiate the AD patients
from the controls using the cutoff points (area under the curve) and
the sensitivity and specificity for each variable of interest.
Analyzing the data in Table 4, we could observe the cutoff
scores, sensitivity, and specificity for the subtests of the VOSP
battery. All of the subtests in which it was observed a statistically
significant difference between the AD and control subjects (except
Dot Counting and Position Discrimination) showed a good ability
to discriminate between the two groups.
The Spearman correlation was used to investigate the
association between the neuropsychological tests that had visuo-
spatial and perceptive components and the VOSP subtests. The
Shape Detection score correlated with the results of the MMSE
(r = 0.317), both of which were used as screening tests (Table 5).
All of the subtests that assessed object perception and two space
perception subtests (Number Location and Cube Analysis)
correlated significantly with the Raven’s test and Boston Naming
Test scores. All of these tests require significant visual-perception
ability.
The Number Location subtest demonstrated a correlation with
the Corsi Block Direct test (r = 0.600); both of these tests require
space-perception skill.
Discussion
In this study, it was assessed visuospatial function in early-stage
of AD using the VOSP battery, which aims to assess these
functions specifically by eliminating the interference of other
cognitive functions.
Table 2. The scores of the control subjects and AD patients on the neuropsychological assessment tests.
Controls Mild AD Patients
Mean (SD) Mean (SD) p-value *
RAVLT - total 40.91 (8.73) 24.48 (5.87) ,0.001
RAVLT - after interference 8.02 (3.20) 2.19 (2.06) ,0.001
RAVLT - after 30 minutes 7.00 (3.27) 0.90 (1.40) ,0.001
Raven - colored version 26.25 (6.89) 18.52 (5.46) ,0.001
Verbal Fluency - animals 17.00 (4.45) 10.87 (3.71) ,0.001
Rey Complex Figure - copy 32.56 (4.03) 25.95 (8.04) ,0.001
Rey Complex Figure - immediate recall 16.38 (5.96) 5.98 (5.50) ,0.001
Rey Complex Figure - delayed recall 19.49 (7.92) 4.92 (6.42) ,0.001
Clock Drawing test 8.41 (2.11) 6.35 (2.59) ,0.01
Corsi - direct (span) 4.93 (1.13) 3.71 (1.58) ,0.001
Corsi - inverse (span) 4.48 (1.07) 4.15 (1.22) 0.012
Boston Naming (15 items) 14.41 (0.84) 12.19 (1.94) ,0.001
Cancellation task (number correct) 49.82 (8.85) 40.19 (1.29) 0.001
Cancellation task (number of errors) 0.41 (1.04) 2.35 (4.05) 0.009
Cancellation task (time in seconds) 161.27 (60.18) 246.13 (48.42) ,0.001
*Mann-Whitney test.
doi:10.1371/journal.pone.0068398.t002
Table 3. Comparison between the AD patients and healthy elderly controls in each VOSP subtest.
Controls Mild AD Patients Mann- Whitney
Mean (SD) Mean (SD) p-value
Screening Shape Detection 19.50 (0.70) 18.90 (1.33) 0.052
Object Perception Incomplete Letters 18.95 (1.31) 16.58 (4.06) 0.004
Silhouettes 19.31 (5.02) 12.10 (4.55) ,0.001
Object Decision 15.68 (2.76) 12.52 (3.47) ,0.001
Progressive Silhouettes 11.27 (2.72) 14.45 (2.84) ,0.001
Space Perception Dot Counting 9.70 (0.67) 9.48 (0.96) 0.252
Position Discrimination 19.23 (1.03) 18.61 (1.73) 0.120
Number Location 8.64 (1.70) 6.68 (2.64) ,0.001
Cube Analysis 8.86 (1.52) 6.55 (2.85) ,0.001
doi:10.1371/journal.pone.0068398.t003
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According to the results, most of the subtests of the VOSP
battery effectively differentiated the patients with mild AD from
the controls; therefore, we suggest that AD patients visuospatial
function is impaired even in the early stages of the disease. This
finding corroborates previous studies, noted by Paxton et al. [36],
stating that early-stage AD patients often have compromised
abilities to draw or copy images and to recognize objects visually in
addition to compromised perceptual organization and space
perception [13,37,38]. However, this finding has been refuted by
other studies, which showed impairment of visuospatial functions
not in early-stage AD but only in more advanced stages of the
disease [17,21].
It is important to note that the screening test showed sensitivity
in discriminating between groups, showing a difference between
groups that was close to statistically significant. This finding is
important because it shows that in this study we were able to
discriminate healthy elderly from AD patients using the Screening
test, implying it is a good screening test to aid in diagnosis.
In this study, we observed that some of the subtests of this
battery are even more sensible to the initial impairment of
visuospatial function in AD, such as the Silhouettes, the
Progressive Silhouettes, and the Cube Analysis. Therefore, we
recommend the use of these subtests, if the battery cannot be used
in its full version.
About the subtests, the results of this study also show that in all
tests that evaluated object perception, there was a significant
difference between the AD patients and controls. Moreover, this
difference was observed in two space perception tests. These
variations in the results concerning the perception of objects and
space may be related to the fact that distinct neural circuits are
responsible for each kind of perception. Visual information is
divided into two pathways: the occipito-parietal (dorsal) and the
occipito-temporal (ventral). The dorsal pathway processes the
information of space ("where") and controls and guides motor
activities, whereas the ventral pathway deals with object recogni-
tion and perceptual judgment ("what") [10,11,12,16,39].
According to this, a study that examined two groups of patients
with AD, one with and one without visuospatial difficulties, using
positron emission tomography (PET) found that the two groups
had reduced cerebral metabolism in the parietal and the medial
and superior temporal regions compared with controls. However,
patients with visuospatial symptoms showed even greater meta-
bolic deficits in the occipital and parietal cortices [40].
Our data are similar to those reported by Lincoln et al. [20],
who observed a significant difference in the performance of AD
patients and controls on the Incomplete Letters and Cube Analysis
subtests. Other studies that used the entire battery observed a
significant impairment in the mild AD patients only on the
Silhouettes subtest [17,21].
The subtests of the VOSP battery correlated significantly with
the neuropsychological tests, such as the Raven and Boston tests,
which are widely used in studies of cognitive evaluation in the
elderly [41,42,43]. Both tests require an important visual
component, which supports our observation that these functions
appear to be compromised early in the course of the disease.
Table 4. ROC curve analysis for VOSP subtests.
AUC (95% CI) Cut-off scores Sensitivity Specificity
Incomplete Letters 0.689* (0.566–0.812) 18 88% 42%
Silhouettes 0.859* (0.771–0.947) 16 76% 83%
Object Decision 0.755* (0.648–0.863) 15 66% 68%
Progressive Silhouettes 0.785*(0.679–0.891) 14 71% 77%
Number Location 0.737* (0.622–0.852) 9 63% 74%
Cube Analysis 0.736* (0.614–0.859) 9 75% 68%
*p,0.01.
doi:10.1371/journal.pone.0068398.t004
Table 5. Correlations of the VOSP subtests.
Tests
Spearman
Correlation Rho
value (N=75) Incomplete LettersSilhouettes Object Decision
Progressive
Silhouettes Number Location Cube Analysis
Raven - colored version 0.579* 0.518* 0.494 20.531* 0.550* 0.600*
Rey Complex Figure - copy 0.445 0.443 0.358 20.324 0.403 0.483
Clock Drawing Test 0.382 0.526* 0.315 20.365 0.338 0.406
Corsi - direct (span) 0.405 0.439 0.367 20.387 0.600* 0.351
Corsi - inverse (span) 0.218 0.352 0.418 20.422 0.480 0.399
Boston Naming (15 items) 0.535* 0.694* 0.586* 20.572* 0.516* 0.615*
Cancellation Task (number of correct) 0.368 0.415 0.474 20.449 0.461 0.429
Cancellation Task (number of errors) 20.378 20.218 20.369 0.193 20.267 20.513
Cancellation task (time, seconds) 20.138 20.447 20.303 0.285 20.241 20.197
*p,0.01.
doi:10.1371/journal.pone.0068398.t005
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The purpose of the VOSP is to assess visuospatial function,
while minimizing the involvement of other cognitive functions. As
shown here, almost all of the tests that assess visuospatial function
require an additional function. We observed that certain subtests
require additional knowledge. For example, the Silhouettes and
Progressive Silhouettes subtests require semantic knowledge. The
Incomplete Letters subtest supposes prior knowledge of the
alphabetic letters. Thus, we can observe the interference, however
small, of other skills in the VOSP.
In Brazil, no studies have been conducted with this battery.
Comparing the preliminary normative data from this population,
we observed differences in the Silhouettes and Progressive
Silhouettes subtest scores, with the Brazilian scores lower than
those observed in the United States and London and closer to
those observed in Spain. As we had a sample with a mean of eight
years of schooling, we believe that these scores are appropriate
without restrictions for this educational level.
Regarding the educational level, we must note that subjects who
are illiterate or have little education show significantly lower
performance on cognitive assessment tests [44]. Ardila, Roselli and
Rosas [45] noted that the performance levels on all evaluated
visuospatial tasks differed significantly between illiterate and highly
educated subjects.
As in a previous survey conducted in the U.S. and one later in
Spain, we observed that the educational level influenced the
performance on the Object Decision and Silhouettes subtests [19].
Age also proved to be an important factor that affected space and
object perception [19]. Gender had no significant effect. There-
fore, we propose the use of the scores obtained in this study for
individuals with an age and education level that was compatible
with those used in this sample.
Given the above findings, we can say that visuospatial function
is impaired in the early stages of Alzheimer’s disease and that the
assessment of these functions can provide important diagnostic
information.
Future studies must assess larger numbers of AD patients at
various stages of the disease to establish a pattern of progression of
visuospatial deficit in addition to patients with mild cognitive
impairment.
The VOSP battery appears to be effective at assessing
visuospatial function and sensitive at detecting visuospatial deficits.
We propose that the data reported here be used as preliminary
normative data for subjects with similar ages and education levels
to the subjects studied.
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